文献速递主动脉疾病

EVAR术后首次随访发现II型内漏患者动脉瘤囊增长的预测因素

Predictive Factors of Aneurysm Sac Growth in Patients with a Type II Endoleak in the First Post-EVAR Control.
PubMed 文献 · Ann Vasc Surg · 2020-04-01

多因素分析显示年龄(HR 14.1)和COPD(HR 9.6)是独立预测因素,内漏瘤腔体积和头尾长度也与瘤囊增长相关。

要点

  • EVAR术后首次CTA发现II型内漏者中约30%在长期随访中出现瘤囊增长>5mm。
  • 年龄增大是瘤囊增长的独立危险因素(HR 14.1),COPD亦为独立预测因素(HR 9.6)。
  • 内漏瘤腔的头尾长度和体积与瘤囊增长相关,但需严格监测。

核心结论

  • 长期瘤囊增长的可靠预测因素仍缺乏,但年龄、COPD及内漏瘤腔体积等变量可能相关,严格监测仍属必要。

主要发现

  • 63例II型内漏患者中男性占90.5%,平均年龄75.7±8岁;中位随访54个月(IQR 56.5)。
  • 19例(30.1%)出现瘤囊增长>5mm。
  • 单因素分析中,年龄(P=0.02)和高脂血症(P=0.03)与瘤囊增长>5mm相关,COPD为保护因素(P=0.02)。
  • 内漏瘤腔头尾长度(P<0.01)和瘤腔体积(P<0.001)是唯一与瘤囊增长相关的动脉瘤相关变量。
  • 多因素分析中,年龄(HR 14.1,95%CI 2.1-92.3,P=0.006)和COPD(HR 9.6,95%CI 1.4-63.7,P=0.019)是仅有的独立预测因素。

临床怎么用

  • 对EVAR术后首次CTA发现II型内漏的患者,应结合年龄、COPD及内漏瘤腔体积/长度评估瘤囊增长风险,并坚持严格影像学随访。

局限性

  • 单中心回顾性设计,样本量有限(63例II型内漏),可能存在选择偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The objective of this study was to identify predictive factors associated with aneurysm sac growth over time in patients diagnosed with a type II endoleak (TII-EL) in the first postoperative control after endovascular aneurysm repair (EVAR). METHODS: A retrospective analysis of all patients undergoing an elective EVAR procedure from January 2003 to December 2011 (9 years) in a single center was performed. Patients with a TII-EL detected in the first post-EVAR imaging control and with over twelve months of follow-up were included. The primary end point was aneurysm sac growth > 5 mm from the first month computed tomography angiography (CTA) to the last available CTA. Demographic variables, cardiovascular risk factors, comorbidities, aneurysm-related data, and procedural information were collected. Three-dimensional volume rendering with the Mimics ® software (Materialise NV, Leuven, Belgium) was used to measure the endoleak nidus. Descriptive, univariate, and multivariate analyses (Cox proportional hazards model) were performed. RESULTS: In this period, 220 EVAR procedures were performed. 63 TII-ELs (28.7%) were detected in the first CTA control (90.5% male, mean age: 75.7 ± 8 years). After a median follow-up of 54 months (interquartile range [IQR], 56.5), aneurysm sac growth > 5 mm was detected in 19 patients (30.1%). Age (P = 0.02) and dyslipidemia (P = 0.03) were associated with sac growth > 5 mm, whereas the presence of chronic obstructive pulmonary disease (COPD) behaved as a protective factor (P = 0.02). The craniocaudal length of the endoleak nidus (P < 0.01) and the nidus volume (P < 0.001) were the only aneurysm-related variables associated with sac growth. Age (HR: 14.1, 95% CI: 2.1-92.3, P = 0.006) and the presence of COPD (HR: 9.6, 95% CI: 1.4-63.7, P = 0.019) were the only independent predictors in the multivariate analysis. CONCLUSIONS: Reliable predictors of long-term aneurysmal sac growth are lacking, although some variables such as age or nidus volume appear to be associated. Strict surveillance remains mandatory.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Arenas Azofra E, Álvarez Marcos F, Fernández Prendes C, et al. Predictive Factors of Aneurysm Sac Growth in Patients with a Type II Endoleak in the First Post-EVAR Control. Ann Vasc Surg. 2020. PMID: 32247062. doi:10.1016/j.avsg.2020.02.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。